Explore the words cloud of the LungCARD project. It provides you a very rough idea of what is the project "LungCARD" about.
The following table provides information about the project.
Coordinator |
STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA
Organization address contact info |
Coordinator Country | Portugal [PT] |
Project website | http://www.lungcardrise.eu |
Total cost | 1˙039˙500 € |
EC max contribution | 976˙500 € (94%) |
Programme |
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) |
Code Call | H2020-MSCA-RISE-2016 |
Funding Scheme | MSCA-RISE |
Starting year | 2017 |
Duration (year-month-day) | from 2017-01-01 to 2020-12-31 |
Take a look of project's partnership.
Lung cancer is the most common cancer worldwide. NSCLC alone make up about 75% of all lung cancers and most hospitals currently test all NSCLC patients for EGFR mutations (pharmacogenomics) for treatment decision (personalised medicine) – i.e., patients with mutation(s) in EGFR gene should receive a EGFR-Tyrosine Kinase Inhibitor (TKI) drug (e.g. afitinib) treatment; while those that do not present mutations in such gene, should be treated with chemotherapy. Currently, the laboratories use PCR and Sanger sequencing technologies to perform the EGFR analysis from tumour biopsies - Fixed Paraffin Embedded (FFPE) samples. Still, some patients (e.g., 30% in UK) may never get histological confirmation because they are too sick to make a biopsy. Furthermore, the results obtained with current methods still present low quality, mainly due to poor quality/low yield of DNA extracted from FFPE samples. The FP7 LungCARD project (www.lungcard.eu) has developed and demonstrated a LungCARD system - an automatic system composed by microfluidic chip and chip analyser - that allows to capture circulating tumour cells (CTCs) from blood samples, amplify by multiplex PCR and detect EGFR mutations, including also a software for data analysis and report. Although this new blood test has proven to be faster, cost-effective and human error-free, the detection of somatic mutations in EGFR gene at frequencies lower than 20% is still a weak point. Therefore, the main project’s goal is to benefit from this technology, through the development, improvement, integration and validation of the LungCARD system with NGS workflow and development of a software for automatic reporting clinical results. However, LungCARD project aims to go further, by putting together a global and unique network of multidisciplinary scientists for exchange of knowledge and research training focused on non-small cell lung cancer.
Report on worldwide research and clinical practices related to Lung cancer pharmacogenomics and therapy | Documents, reports | 2019-05-30 15:17:14 |
Mid-term report on outreach activities (including participation in international events, workshops, seminars and publications) | Documents, reports | 2019-05-14 14:48:17 |
Project Website | Websites, patent fillings, videos etc. | 2019-05-30 15:32:25 |
Take a look to the deliverables list in detail: detailed list of LungCARD deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Radmila Jankovic1
, Helena J. Goncalves2
, Milena Cavic1
, Carla Clemente2
, Michael Lind3
,
Alexis Murillo Carrasco4
, Selama Nadifi5
, Meriem Khyatti6
, Tumininu Adebambo7
, Dilshod
Egamberdiev8
1
Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; 2
StabVida, Caparica, Portugal; 3
University of HULL, UK; 4
Centro
de Genética y BiologÃa Molecular, Facultad de Medicina Humana, Universidad de San MartÃn de Porres, Lima, Peru; 5
Universite
Hassan II de Casablanca, Morocco; 6
Institut Pasteur Du Maroc, Morocco; 7
Federal University of Agriculture, Nigeria; 8
National
Cancer Center of Uzbekistan, Uzbekistan. LungCARD - Report on worldwide research and clinical practices related to lung cancer published pages: , ISSN: 1107-0625, DOI: |
JBUON Open Access Journal aimed at the rapid diffusion of scientific knowledge in Oncology. | 2019-05-14 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LUNGCARD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LUNGCARD" are provided by the European Opendata Portal: CORDIS opendata.
Outcomes of Patients’ Evidence With Novel, Do-It-Yourself Artificial Pancreas Technology
Read MoreIdentifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategy
Read MoreIrradiation driven nanofabrication: computational modelling versus experiment
Read More